Oncology Information Systems Market Regional Analysis

Oncology Information Systems Market size was valued at USD 2.21 Billion in 2023 and is poised to grow from USD 2.38 Billion in 2024 to USD 4.38 Billion by 2032, growing at a CAGR of 7.9% during the forecast period (2025-2032).

Key Vendors in Oncology Information Systems Market are: 'Epic Systems Corporation', 'Cerner Corporation', 'Elekta AB', 'Varian Medical Systems, Inc.', 'Philips Healthcare', 'McKesson Corporation', 'GE Healthcare', 'Siemens Healthineers', 'Accuray Incorporated', 'RaySearch Laboratories AB', 'CureMD Healthcare', 'Flatiron Health, Inc.', 'MIM Software Inc.', 'Elekta Inc.', 'IBM Watson Health', 'Impac Software (Varian)', 'EpicCare Oncology', 'RayCare (RaySearch)', 'MOSAIQ Oncology (Elekta)', 'OncoEMR (CureMD)'

Increasing cancer burden across the globe is a major driver for the oncology information systems market. According to the World Health Organization (WHO), cancer is one of the leading causes of death worldwide, requiring effective solutions for treatment planning, data management and patient care. OIS systems for oncology departments are facilitated by the sharing of real-time information, which improves the accuracy of treatment and improving patient outcomes is further reinforced by drugs. 

Integration of Artificial Intelligence in OIS :A key oncology information systems market trend is the integration of artificial intelligence (AI) to improve treatment accuracy and efficiency. AI-powered systems are able to analyze large data sets to identify patterns and predict how patients will respond to treatments. This integration not only reduces human error, but also speeds up decision making, especially in complex cases. Companies are investing in AI-powered modules to give OIS a competitive advantage and meet the growing demand for advanced oncology care.  

As per oncology information systems market outlook, the North America regional market accounted for the largest revenue share at 38.3% in 2023. The major factors driving this growth were availability of advanced healthcare infrastructure, increased awareness in patient data management in the region. The increasing adoption of OIS to track and record treatment results of cancer patients and the rising importance of EMR for making better treatment decisions are expected to boost the regional market growth. The increasing importance of treatment regimen monitoring, dosing and treatment planning is also expected to increase the demand for OIS in this region.